MAPT and Alzheimer disease: The reduction in CSF Aβ42 levels likely results from selective retention of Aβ42 in Aβ plaques, while the increase in t-tau and p-tau levels in CSF reflect increased tau secretion and phosphorylation from neurons affected by AD [4, 5].